Nynne Nyboe Andersen, MD

Nynne Nyboe Andersen
PhD student
Statens Serum Institut
5 Artillerivej , 206/204
DK-2300 Copenhagen S
+45 3268 3268


Nynne Nyboe Andersen is as of 1st of June 2012 employed by the Department of Epidemiology Research with the primary objective to conduct a Ph.D thesis within the field of Gastroenterology. Nynne Nyboe Andersen is educated as a medical doctor in January 2011 from the University of Copenhagen.

Research area

Gatroenterology, epidemiological research.

Is presently conducting the PhD study 'Safety of Anti-Tumor Necrosis Factor - alpha Treatment - A nationwide Cohort Study'.

Selected publications

  • Rungoe C, Andersen NN, Jess T Inflammatory bowel disease and risk of coronary heart disease. Trends Cardiovasc Med.2015; In press,
  • Andersen NN, Pasternak B, Friis-Møller N, Andersson M, Jess T Association between tumor necrosis factor-alpha inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study. BMJ.2015; 350, h2809
  • Andersen NN, Pasternak B, Andersson M, Nielsen NM, Jess T Risk of demyelinating diseases in the central nervous system in patients with inflammatory bowel disease treated with tumor necrosis factor inhibitors. JAMA Intern Med.2015; Oct 5:1-2 doi: 10.1001 [Epub ahead of print],
  • Andersen NN, Pasternak B, Basit S, Andersson M, Svanström H, Caspersen S, Munkholm P, Hviid A, Jess T Association between tumor necrosis factor-alpha antagonists and risk of cancer in patients with inflammatory bowel disease. JAMA.2014; 311, 2406-2413 PubMed
  • Andersen NN, Jess T Risk of cardiovascular disease in inflammatory bowel disease. World J Gastrointestinal Pathophysiology.2014; 5, 359-365